Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,614Revenue $M96.5Net Margin (%)-168.5Z-Score4.5
Enterprise Value $M3,606EPS $-0.3Operating Margin %-137.7F-Score2
P/E(ttm))0Cash Flow Per Share $-0.0Pre-tax Margin (%)-161.1Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %4.4Quick Ratio2.1Cash flow > EarningsY
Price/Sales38.55-y EBITDA Growth Rate %27.0Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-12.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-19.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M414ROI % (ttm)-1.2Gross Margin Increase y-yN

Gurus Latest Trades with OPK

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OPKGeorge Soros 2014-06-30 Reduce-0.12%$8.01 - $9.71
($8.73)
$ 8.46-3%Reduce -84.24%235,600
OPKGeorge Soros 2014-03-31 Add0.06%$7.58 - $9.96
($8.75)
$ 8.46-3%Add 76.98%1,494,800
OPKGeorge Soros 2013-09-30 Buy 0.07%$7.18 - $9.24
($8.02)
$ 8.466%New holding, 745000 sh.745,000
OPKMario Gabelli 2011-03-31 Reduce$3.48 - $4.83
($4.01)
$ 8.46111%Reduce -90.58%15,000
OPKMario Gabelli 2010-09-30 Add$2.07 - $2.6
($2.31)
$ 8.46266%Add 962%159,300
OPKMario Gabelli 2010-06-30 Reduce$1.87 - $2.55
($2.11)
$ 8.46301%Reduce -90%15,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OPK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
OPK Mario Gabelli 2014-06-3015,00000
OPK George Soros 2014-06-30235,6000.060.02-84.24%
Premium Most recent portfolio changes are included for Premium Members only!


OPK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-18Buy40,000$8.49-0.35view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-16Buy25,000$8.49-0.35view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-15Buy20,000$8.52-0.7view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-12Buy15,000$8.57-1.28view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-11Buy20,000$8.54-0.94view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-10Buy10,000$8.55-1.05view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-09Buy35,700$8.55-1.05view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-05Buy58,000$8.48-0.24view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-04Buy35,000$8.6-1.63view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-09-02Buy10,000$8.78-3.64view

Press Releases about OPK :

Quarterly/Annual Reports about OPK:

News about OPK:

Articles On GuruFocus.com
Weekly CEO Buys Highlight: TITN, OPK, LDOS, FSFR, BRX Sep 16 2014 
Weekly CEO Buys Highlight: OPK, BOBE, CONN, WPX, PHII Sep 08 2014 
Weekly CEO Buys Highlight: TDG, OPK, QNST, PVA, CIO Sep 02 2014 
Weekly CEO Buys Highlight: FSFR, FSIC, OPK, EPE, ACXM Aug 23 2014 
Weekly CEO Buys Highlight: FSIC, NLY, OPK, GPC, ACXM Aug 17 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Buys Highlight: OPK, LJPC, SFNC, HAFC, TUBE Jul 28 2014 
Weekly CEO Buys Highlight: OPK, QTET, MIC, FAST, OCRX Jul 21 2014 
Top Insider Buys Highlight: Opko Health Inc. Jul 17 2014 
Weekly CEO Buys Highlight: OPK, GBIM, RICK Jul 15 2014 

More From Other Websites
OPKO Launches the 4Kscore Test in Europe Sep 15 2014
Opko (OPK) Sees Hammer Chart Pattern: Time to Buy? Sep 12 2014
Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be... Sep 11 2014
TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant Sep 09 2014
OPKO Licensee TESARO Submits New Drug Application for Rolapitant Sep 08 2014
OPKO HEALTH, INC. Financials Aug 19 2014
'Mad Money' Lightning Round: Don't Buy IBM Right Now Aug 14 2014
Opko’s Frost Discusses Treatment of Kidney Disease (Audio) Aug 13 2014
Taking Stock: Manley on Markets, Frost on Biotech (Audio) Aug 12 2014
Taking Stock: Manley on Markets, Frost on Biotech Aug 12 2014
OPKO HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 12 2014
OPKO HEALTH, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
OPKO Announces Second Quarter Operating and Financial Results Aug 11 2014
Rayaldee Phase 3 Trial Meets Primary Endpoints Aug 11 2014
Q2 2014 Opko Health Inc. Earnings Release - After Market Close Aug 11 2014
OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy Aug 07 2014
OPKO to Announce Top Line RAYALDEE Results and Second Quarter 2014 Financial Results on August 11,... Aug 07 2014
Bob McNamara, the Executive Vice President and CFO of LDR Holding Corporation (LDRH), Interviews... Aug 01 2014
[video] What's coming in biotech? Jul 23 2014
OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE Jul 22 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK